CTRI/2023/05/052618进行中（未招募）4 期
A phase IV, prospective, open label, single-arm, multicenter clinical study to evaluate the safety and efficacy of teriparatide in patients with postmenopausal osteoporosis.
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Women with at least 5 years of post menopause, aged > 50 to 80 years
- •2. Postmenopausal women with osteoporosis
排除标准
- •1. known hypersensitivity to teriparatide or any of its excipients
- •2. pre-existing hypercalcemia
- •3. severe renal impairment
- •4. metabolic bone diseases other than postmenopausal osteoporosis.
- •5. unexplained elevation of alkaline phosphatase
- •6. Prior external beam or implant radiation therapy to the skeleton.
- •7. patients with skeletal malignancies or bone metastases should be excluded from the treatment with teriparatide.
- •8. Any significant medical condition in the opinion of the investigator that does not allow the participation of the patient in the study.
研究者
相似试验
尚未招募
4 期
Assessing the Efficacy and Durability of Faricimab in Patients Currently Treated for Neovascular Age-Related Macular Degeneration.ACTRN12623000215628CUREOS150
进行中（未招募）
不适用
SSAT046 Addition of Maraviroc to monotherapy Darunavir/Ritonavir studyEUCTR2012-000649-11-ESSt Stephen's AIDS Trust40
招募中
4 期
A study to evaluate the safety and efficacy of Bevacizumab in approved indications.CTRI/2017/12/010893Intas Pharmaceuticals Limited
进行中（未招募）
1 期
A Phase IV, prospective, open-label, uncontrolled, single-centre cohort trial to be conducted in Norway to assess the responsiveness of subjects with phenylketonuria (PKU) to treatment with Kuvan® 20 mg/kg/day for 7 days. - Response to Kuvan® in subjects with PKU from a single centre in NorwayHyperphenylalaninemia (HPA) in adults and children >=16 years of age with phenylketonuri (PKU) (classic or mild PKU, or mild hyperphenylalaninemia (HPA)).MedDRA version: 9.1Level: LLTClassification code 10034872Term: PhenylketonuriaMedDRA version: 9.1Level: LLTClassification code 10034873Term: Phenylketonuria (PKU)MedDRA version: 9.1Level: PTClassification code 10034872Term: PhenylketonuriaMedDRA version: 9.1Level: LLTClassification code 10034871Term: PhenylalaninemiaEUCTR2009-012978-12-NOMerck Serono, an affiliate of E. Merck AB
已完成
不适用
A phase 4, longitudinal, single-arm, open-label treatment study of subcutaneous golimumab effectiveness assessed by both speed of magnetic resonance imaging (MRI) changes in the hand/wrist and clinical response outcomes in patients with rheumatoid arthritis.Inflammatory and Immune System - Rheumatoid arthritisRheumatoid arthritisACTRN12620000827932Emeritus Research Pty Ltd18